指南&解读指南

订阅

MedSci主页 / 所有栏目 / 指南&解读指南

胆道肿瘤临床实践指南（英文第三版）

2021-04-25 中华消化外科杂志.2021.20(4):359-375.

胆道肿瘤

英文第三版胆道肿瘤临床实践指南的出版是为了向全世界介绍日本关于胆道肿瘤临床诊断与治疗的最新指南。本文为该指南的中文翻译版。

中文标题：

胆道肿瘤临床实践指南（英文第三版）

发布机构：

发布日期：

2021-04-25

简要介绍：

英文第三版胆道肿瘤临床实践指南的出版是为了向全世界介绍日本关于胆道肿瘤临床诊断与治疗的最新指南。本文为该指南的中文翻译版。

相关资料下载：
[AttachmentFileName(sort=1, fileName=胆道肿瘤临床实践指南（英文第三版）.pdf)] GetToolGuiderByIdResponse(projectId=1, id=04c1c1c002108154, title=胆道肿瘤临床实践指南（英文第三版）, enTitle=, guiderFrom=中华消化外科杂志.2021.20(4):359-375., authorId=0, author=, summary=英文第三版胆道肿瘤临床实践指南的出版是为了向全世界介绍日本关于胆道肿瘤临床诊断与治疗的最新指南。本文为该指南的中文翻译版。, cover=https://img.medsci.cn/2021529/1622302429150_2020535.jpg, journalId=0, articlesId=null, associationId=0, associationName=, associationIntro=, copyright=0, guiderPublishedTime=Sun Apr 25 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #333333;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>英文第三版胆道肿瘤临床实践指南的出版是为了向全世界介绍日本关于胆道肿瘤临床诊断与治疗的最新指南。本文为该指南的中文翻译版。</p> </div> </div> </div>, tagList=[TagDto(tagId=2871, tagName=胆道肿瘤)], categoryList=[CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=91, categoryName=肝胆胰外科, tenant=100), CategoryDto(categoryId=20620, categoryName=肿瘤医学网, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=2871, guiderKeyword=胆道肿瘤, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=4890, appHits=94, showAppHits=0, pcHits=382, showPcHits=4796, likes=4, shares=9, comments=5, approvalStatus=1, publishedTime=Sun May 30 00:27:55 CST 2021, publishedTimeString=2021-04-25, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Sat May 29 23:33:56 CST 2021, updatedBy=2020535, updatedName=qiushida2, updatedTime=Wed Jan 03 07:52:17 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=胆道肿瘤临床实践指南（英文第三版）.pdf)])
胆道肿瘤临床实践指南（英文第三版）.pdf
下载请点击：
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1058421, encodeId=f0ef105842127, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=79885315411, createdName=14898059m33暂无昵称, createdTime=Thu Oct 07 17:44:44 CST 2021, time=2021-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056618, encodeId=39b0105661865, content=学习中, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJ1CXL3QKAG2ibC1mTEnpicKoFOLVPgO2ibqP9uLltgEw1M9kC1Siay0UH7zbYb8tEfVvDdlAu0nejLzw/132, createdBy=94bf109446, createdName=wquick, createdTime=Thu Sep 30 18:48:43 CST 2021, time=2021-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997752, encodeId=42c299e75220, content=好好学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9fc5545008, createdName=ljqLJQ, createdTime=Fri Jul 09 05:41:25 CST 2021, time=2021-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971216, encodeId=d2f49e121630, content=来学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210605/576afffbe3f5466fafbb32f3fb27a807/59838bfedef9485e864dcb907e812f0e.jpg, createdBy=32ce5513808, createdName=ori丶, createdTime=Sat Jun 05 23:24:07 CST 2021, time=2021-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970822, encodeId=d79f9e08220b, content=感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210604/6415dd90cefb4b0a9f2cc4a58fc6c08e/90a9c41a6596419ab0040f393375692b.jpg, createdBy=a69a5353576, createdName=药生尘8738, createdTime=Fri Jun 04 10:33:54 CST 2021, time=2021-06-04, status=1, ipAttribution=)]
    2021-10-07 14898059m33暂无昵称

    学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1058421, encodeId=f0ef105842127, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=79885315411, createdName=14898059m33暂无昵称, createdTime=Thu Oct 07 17:44:44 CST 2021, time=2021-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056618, encodeId=39b0105661865, content=学习中, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJ1CXL3QKAG2ibC1mTEnpicKoFOLVPgO2ibqP9uLltgEw1M9kC1Siay0UH7zbYb8tEfVvDdlAu0nejLzw/132, createdBy=94bf109446, createdName=wquick, createdTime=Thu Sep 30 18:48:43 CST 2021, time=2021-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997752, encodeId=42c299e75220, content=好好学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9fc5545008, createdName=ljqLJQ, createdTime=Fri Jul 09 05:41:25 CST 2021, time=2021-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971216, encodeId=d2f49e121630, content=来学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210605/576afffbe3f5466fafbb32f3fb27a807/59838bfedef9485e864dcb907e812f0e.jpg, createdBy=32ce5513808, createdName=ori丶, createdTime=Sat Jun 05 23:24:07 CST 2021, time=2021-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970822, encodeId=d79f9e08220b, content=感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210604/6415dd90cefb4b0a9f2cc4a58fc6c08e/90a9c41a6596419ab0040f393375692b.jpg, createdBy=a69a5353576, createdName=药生尘8738, createdTime=Fri Jun 04 10:33:54 CST 2021, time=2021-06-04, status=1, ipAttribution=)]
    2021-09-30 wquick

    学习中

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1058421, encodeId=f0ef105842127, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=79885315411, createdName=14898059m33暂无昵称, createdTime=Thu Oct 07 17:44:44 CST 2021, time=2021-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056618, encodeId=39b0105661865, content=学习中, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJ1CXL3QKAG2ibC1mTEnpicKoFOLVPgO2ibqP9uLltgEw1M9kC1Siay0UH7zbYb8tEfVvDdlAu0nejLzw/132, createdBy=94bf109446, createdName=wquick, createdTime=Thu Sep 30 18:48:43 CST 2021, time=2021-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997752, encodeId=42c299e75220, content=好好学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9fc5545008, createdName=ljqLJQ, createdTime=Fri Jul 09 05:41:25 CST 2021, time=2021-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971216, encodeId=d2f49e121630, content=来学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210605/576afffbe3f5466fafbb32f3fb27a807/59838bfedef9485e864dcb907e812f0e.jpg, createdBy=32ce5513808, createdName=ori丶, createdTime=Sat Jun 05 23:24:07 CST 2021, time=2021-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970822, encodeId=d79f9e08220b, content=感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210604/6415dd90cefb4b0a9f2cc4a58fc6c08e/90a9c41a6596419ab0040f393375692b.jpg, createdBy=a69a5353576, createdName=药生尘8738, createdTime=Fri Jun 04 10:33:54 CST 2021, time=2021-06-04, status=1, ipAttribution=)]
    2021-07-09 ljqLJQ

    好好学习一下

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1058421, encodeId=f0ef105842127, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=79885315411, createdName=14898059m33暂无昵称, createdTime=Thu Oct 07 17:44:44 CST 2021, time=2021-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056618, encodeId=39b0105661865, content=学习中, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJ1CXL3QKAG2ibC1mTEnpicKoFOLVPgO2ibqP9uLltgEw1M9kC1Siay0UH7zbYb8tEfVvDdlAu0nejLzw/132, createdBy=94bf109446, createdName=wquick, createdTime=Thu Sep 30 18:48:43 CST 2021, time=2021-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997752, encodeId=42c299e75220, content=好好学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9fc5545008, createdName=ljqLJQ, createdTime=Fri Jul 09 05:41:25 CST 2021, time=2021-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971216, encodeId=d2f49e121630, content=来学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210605/576afffbe3f5466fafbb32f3fb27a807/59838bfedef9485e864dcb907e812f0e.jpg, createdBy=32ce5513808, createdName=ori丶, createdTime=Sat Jun 05 23:24:07 CST 2021, time=2021-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970822, encodeId=d79f9e08220b, content=感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210604/6415dd90cefb4b0a9f2cc4a58fc6c08e/90a9c41a6596419ab0040f393375692b.jpg, createdBy=a69a5353576, createdName=药生尘8738, createdTime=Fri Jun 04 10:33:54 CST 2021, time=2021-06-04, status=1, ipAttribution=)]
    2021-06-05 ori丶

    来学习

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1058421, encodeId=f0ef105842127, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=79885315411, createdName=14898059m33暂无昵称, createdTime=Thu Oct 07 17:44:44 CST 2021, time=2021-10-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056618, encodeId=39b0105661865, content=学习中, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJ1CXL3QKAG2ibC1mTEnpicKoFOLVPgO2ibqP9uLltgEw1M9kC1Siay0UH7zbYb8tEfVvDdlAu0nejLzw/132, createdBy=94bf109446, createdName=wquick, createdTime=Thu Sep 30 18:48:43 CST 2021, time=2021-09-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=997752, encodeId=42c299e75220, content=好好学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9fc5545008, createdName=ljqLJQ, createdTime=Fri Jul 09 05:41:25 CST 2021, time=2021-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971216, encodeId=d2f49e121630, content=来学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210605/576afffbe3f5466fafbb32f3fb27a807/59838bfedef9485e864dcb907e812f0e.jpg, createdBy=32ce5513808, createdName=ori丶, createdTime=Sat Jun 05 23:24:07 CST 2021, time=2021-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=970822, encodeId=d79f9e08220b, content=感谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210604/6415dd90cefb4b0a9f2cc4a58fc6c08e/90a9c41a6596419ab0040f393375692b.jpg, createdBy=a69a5353576, createdName=药生尘8738, createdTime=Fri Jun 04 10:33:54 CST 2021, time=2021-06-04, status=1, ipAttribution=)]
    2021-06-04 药生尘8738

    感谢

    0

拓展阅读

胆道肿瘤患者的营养治疗共识

中国抗癌协会肿瘤营养与支持治疗专业委员会 · 2021-06-09